SEC filing record
Primary Source · SEC.gov

PolyPid Ltd.

2025 vintageRule 506(b)Filing record

Built from the SEC filing index the day the filing landed. The figures below are the issuer's own from Form D; AltStreet's analysis, sponsor link and data flags follow when the entity is enriched.

Latest signalNew Form D filerForm D · 2025-06-23Last filing 2025-06-23

Raised

$27M

Investors

20

Min Invest

None stated

AltStreet Verified Issuer badge

Is this your company or fund? Claim this page free, or verify it and carry the Verified Issuer mark.

What this filing shows

·

Every sentence is a value as filed on SEC Form D

PolyPid Ltd. is a Israel corporation that filed a Form D with the SEC on June 23, 2025 in the Biotechnology industry group. The offering claims Rule 506(b) and covers equity. PolyPid Ltd. reported $26,692,799 sold from 20 investors of a $26,692,799 total offering as of the Form D filed June 23, 2025. The offering relies on Rule 506(b), which permits sales to accredited investors and to no more than 35 non-accredited investors who meet a sophistication standard, and prohibits general solicitation. The filing reports no non-accredited investors. The filing lists the minimum investment as $0, meaning no minimum was stated. The Form D names no recipient of sales compensation, which usually means the issuer or its affiliates are placing the securities directly. Sales commissions are reported as $0 and finders' fees as $0. Form D allows these to be estimates. The issuer's address of record is 18 Hasivim Street, Petach Tikva, Israel 4959376.

EDGAR Filing Data

Form D — Primary Source

View on SEC.gov
CIK Number0001611842
Entity NamePolyPid Ltd.
ExemptionRule 506(b)
What the exemption meansRule 506(b) of Regulation D: securities may be sold to an unlimited number of accredited investors and up to 35 non-accredited investors who meet the rule's sophistication standard, without general solicitation or advertising.
Entity TypeCorporation
Jurisdiction of OrganizationIsrael
Issuer Address18 Hasivim Street, Petach Tikva, Israel 4959376
Phone972-74-7195700
Industry / Fund TypeBiotechnology
Securities TypeEquity
First Sale DateJune 16, 2025
Filing DateJune 23, 2025
Accession Number0001213900-25-056691
Total Offering Amount$26,692,799
Total Amount Sold$26,692,799
Amount Remaining$0
Total Investors20
Non-Accredited InvestorsNone
Minimum Investment$0 (no stated minimum)
Offering DurationOne year or less
Sales Commissions$0
Finders' Fees$0
Revenue RangeNo Revenues
State (Issuer Address)L3
Amendment Count6 filings on record

Filings on Record

Every filing AltStreet's ledger holds for this CIK, newest first. Each opens the SEC archive folder.

In the Terminal

Filing events

4

latest Jun 23, 2025

Critical / warning

0 / 0

2 watch · 2 info

Statements extracted

0

none on file

NAV prints

0

none on file

Offering chains

6

closed, lapsed

Latest event New filer · Jun 23, 2025

SEC.gov
Open in the terminal Watch this issuerInvestor $149/mo unlocks the values; Pro $349/mo adds the universe.

Investor

  • 4 filing events with values and deltas, latest 2025-06-23, and alerts on the next one
  • 6 offering timelines: velocity, share raised, first-sale lag, stalled flags

Pro

  • This issuer against its cohort: rank by velocity and share raised among offerings filed the same quarter
  • The same events, statements and NAV moves across every issuer, screenable, with unlimited watches and CSV

Counts and dates above are the free record. The values, the series and the comparisons are the seat. Loading your view…

Related Persons (Form D)

Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.

Item 3 changed on the Form D filed 2025-06-23: 1 related person added and 0 removed against the filing of 2025-01-02; 12 now listed. The names are in the Terminal feed.

Dikla Czaczkes Akselbrad

Executive Officer · Petach Tikva, L3

Dalit Hazan

Executive Officer · Petach Tikva, L3

Ori Warshavsky

Executive Officer · Petach Tikva, L3

Jonny Missulawin

Executive Officer · Petach Tikva, L3

Jacob Harel

Director · Petach Tikva, L3

Yechezkel Barenholz

Director · Petach Tikva, L3

Nir Dror

Director · Petach Tikva, L3

Yossi BenAmram

Director · Petach Tikva, L3

Itzhak Krinsky

Director · Petach Tikva, L3

Robert B. Stein

Director · Petach Tikva, L3

Nurit Tweezer-Zaks

Director · Petach Tikva, L3

Yitzchak Jacobovitz

Director · Petach Tikva, L3

Questions About PolyPid Ltd.

Each answer is built from the values on the SEC filing and the AltStreet ledger, not from the issuer's marketing.

What is PolyPid Ltd.?

PolyPid Ltd. is a Israel corporation that filed a Form D with the SEC on June 23, 2025 in the Biotechnology industry group. The filing claims Rule 506(b) for an offering of equity.

Is PolyPid Ltd. legit?

AltStreet does not rate legitimacy; it reports the public record. PolyPid Ltd. filed a Form D with the SEC on June 23, 2025 claiming Rule 506(b). A Form D is a notice of an exempt offering, not a review or approval of it. The newest notice reports $26,692,799 sold to 20 investors. AltStreet's enforcement record (SEC, FINRA and state actions) shows no action naming the issuer as of today. Before investing, confirm the filing on EDGAR, check the seller's registration on FINRA BrokerCheck, and read the offering documents, which a Form D does not include.

Is PolyPid Ltd. registered with or approved by the SEC?

No. A Form D is a notice that an issuer is selling securities under an exemption from registration, and the SEC does not review, approve, or pass on the merits of the offering. The filing shows that PolyPid Ltd. claimed Rule 506(b) and disclosed the items the form requires, such as the amount sold, the minimum investment, related persons, and anyone paid to sell the securities. It does not verify the issuer's claims or its business.

How much has PolyPid Ltd. raised?

PolyPid Ltd. reported $26,692,799 sold from 20 investors of a $26,692,799 total offering as of the Form D filed June 23, 2025.

Who can invest in PolyPid Ltd.?

The offering relies on Rule 506(b), which permits sales to accredited investors and to no more than 35 non-accredited investors who meet a sophistication standard, and prohibits general solicitation. The filing reports no non-accredited investors. The filing lists the minimum investment as $0, meaning no minimum was stated.

What is the minimum investment in PolyPid Ltd.?

The Form D lists the minimum investment as $0, which means the issuer did not state a minimum on the form. The offering documents, not the Form D, set the actual subscription terms.

Who is selling PolyPid Ltd. and how are they paid?

The Form D names no recipient of sales compensation, which usually means the issuer or its affiliates are placing the securities directly. Sales commissions are reported as $0 and finders' fees as $0. Form D allows these to be estimates.

Who is behind PolyPid Ltd.?

The Form D lists 12 related persons: Dikla Czaczkes Akselbrad, executive officer; Dalit Hazan, executive officer; Ori Warshavsky, executive officer; Jonny Missulawin, executive officer; Jacob Harel, director; Yechezkel Barenholz, director; Nir Dror, director; Yossi BenAmram, director, and 4 more. Form D Item 3 requires executive officers, directors, and promoters of the issuer to be listed.

Where is PolyPid Ltd. located?

The issuer's address on its SEC filings is 18 Hasivim Street, Petach Tikva, Israel 4959376. Its phone number of record is 972-74-7195700. It is organized under the laws of Israel.

How long is the PolyPid Ltd. offering open?

The issuer indicated that the offering is not intended to last more than one year. An issuer must amend its Form D annually while a continuing offering stays open, and no amendment is on record yet.

What is PolyPid Ltd.'s revenue?

The Form D reports a revenue range of No Revenues.

AltStreet Verified Issuer badge

Is this your company or fund?

Free claim: add your contact details, website, team and a description to this page. The filed facts stay as filed.

Verified Issuer, $480 a year: AltStreet checks the identity of your company and the authority of the person claiming it against your filings, confirms your contact details on a stated date and again at each renewal, and marks the page so people researching you find a current, attributed profile beside the public filing record. It is not a review of any offering.

Data Methodology

Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.